14/January/22

 

Texas vineyard owners allege their crops were damaged by dicamba herbicide, which drifts from GM dicamba-tolerant soy and cotton fields. Now a US district judge has decided to send the Texas High Plains wine grape growers’ suit against Bayer and BASF to a Texas state court. Lawyer Adam Dinnell said, "The Texas wine industry has been treated as a cost of doing business by Bayer and BASF, and has been decimated in the process." SHJ Law Firm

 

 

Billionaire philanthropists are pushing US agribusiness models around the globe—including in Africa. Industrial agriculture is the single largest cause of biodiversity loss worldwide, fails to solve hunger, and hurts small-scale farmers. Learn more in this short film series. Rich Appetites

 

 

GeneWatch UK has published its response to the UK Food Standards Agency (FSA) public consultation on applications for nine genetically modified organisms for food and feed uses, which are already approved in the EU for the same uses after gaining favourable opinions from EFSA. GeneWatch UK states, "In all cases, the risk assessment is inadequate to establish safety, proposals for monitoring are inadequate, and other legitimate factors (lack of labelling of GM-fed meat and dairy products, concerns regarding adverse environmental impacts in the countries where GM crops are grown, and concerns regarding the patenting of seeds) should lead to refusal of the import authorisations for these GM crops." GeneWatch UK

 

 

Science depends on sharing data, fierce debate and challenging evidence – and few scientific investigations are more important than discovering the origins of COVID to help guard against future disasters. Yet Sir Jeremy Farrar, director of the world-famous Wellcome Trust, agreed with other top British and US scientists to label as "conspiracy theory" any suggestions the novel strain of coronavirus responsible might be linked to a laboratory incident in the Chinese city of Wuhan, where it first emerged. Reporter Ian Birrell writes, "It seems incredible that not only does Farrar remain in a job in which he directs so much crucial medical research, but even saw his annual salary rise by £28,000 to £512,000 last year, according to latest accounts." Daily Mail